OCREUS Group

Drugs giant Pfizer has been fined a record £84.2m by the UK’s competition regulator after the price charged to the NHS for an anti-epilepsy drug was increased by up to 2,600%.

WP to LinkedIn Auto Publish Powered By : XYZScripts.com